sellWeak
Nicole Negar Davarpanah sold $30k of CDTX
Chief Medical Officer at Cidara Therapeutics, Inc.. 474 shares at an average of $62.86, traded Sep 11, 2025, filed Sep 15, 2025.
Warning score
20Value
$30k
474 shares
Holdings after
31,418
-1% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- +5Trade size$30k at market
- 0Share of holdings soldSold 1.5% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001610618-25-000086, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 11, 2025 | SOpen-market sale Common Stock | -474 | $62.86 | $30k | 31,418 | Sep 15, 2025 |
Related signals
Other insiders at Cidara Therapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 43Moderate | CDTXbuy Cidara Therapeutics, Inc. | Jeffrey Stein President & CEO | $339k 4,262 shares | +7% | |
| 40Moderate | CDTXsell Cidara Therapeutics, Inc. | Shane Ward COO & CLO | $2.2M 9,959 shares | -28% | |
| 50Moderate | CDTXbuy Cidara Therapeutics, Inc. | Ra Capital Management, L.p. director, owner | $100M 2,272,727 shares | +208% | |
| 31Weak | CDTXbuy Cidara Therapeutics, Inc. | Chrysa Mineo director | $74k 3,320 shares | - | |
| 29Weak | Cidara Therapeutics, Inc. | Leslie Tari CHIEF SCIENTIFIC OFFICER | $39k 1,773 shares | -10% | |
| 39Weak | Cidara Therapeutics, Inc. | Shane Ward COO & CLO | $37k 1,664 shares | -10% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.